We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bayer's Trasylol Doubles Risk Of Kidney Failure
Bayer's Trasylol Doubles Risk Of Kidney Failure
February 8, 2006
Bayer Pharmaceutical's Trasylol for treating blood-loss doubles a patient's risk of kidney failure and increases risks of heart attack, heart failure and stroke, according to a study published in the New England Journal of Medicine (NEJM).